CervoMed Inc. is a clinical-stage biotech company working to develop treatments for neurodegenerative disorders, navigating the challenges and opportunities of the biotech sector.

CervoMed Inc. is a clinical-stage biotech company pioneering neurodegenerative treatment innovation, with a promising pipeline and strategic initiatives to address complex central nervous system disorders.